Literature DB >> 16961172

A new predictor of risk for sudden cardiac death.

Rowa Jabbar1, Tom Saldeen.   

Abstract

BACKGROUND: Long-chain fatty acids, particularly omega-3 fatty acids found primarily in fish oil, are beneficial in different physiological conditions in the human body. High intake of omega-3 fatty acids has been found to have a strong inverse relationship to sudden cardiac death. An index showing the relationship between different fatty acids in the blood could be an important risk indicator for sudden cardiac death.
METHODS: Whole-blood samples from the fingertip were collected and fatty acids were measured by a new simple method using direct transmethylation. Two groups were compared: subjects who had been taking fish oil daily during the last 6 years, and subjects who had not been taking fish oil.
RESULTS: Six different fatty acid indices were calculated. Five of them take both DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) into consideration, and the sixth includes only EPA and not DHA in the calculation. This latter index, the ratio between EPA and arachidonic acid, gave the best result, with the largest difference between the two groups. This index varied between 5 and 118 among the different individuals; 70% of the fish oil consumers having an index > or =50. Based on the present knowledge about the relationship between blood levels of omega-3 fatty acids and sudden cardiac death obtained from studies of 14,000 individuals, a subject with an index below 50 should be advised to increase his/her intake of omega-3 fatty acids.
CONCLUSION: The EPA/arachidonic acid index may be an important new predictor of risk for sudden cardiac death, and reflects the individual requirement for consumption of omega-3 fatty acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961172     DOI: 10.3109/2000-1967-033

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  5 in total

1.  Influence of different supplementation on platelet aggregation in patients with rheumatoid arthritis.

Authors:  Marijana Tomic-Smiljanic; Dragan Vasiljevic; Aleksandra Lucic-Tomic; Nebojsa Andjelkovic; Vladimir Jakovljevic; Sergey Bolovich; Mirjana Veselinovic
Journal:  Clin Rheumatol       Date:  2019-05-10       Impact factor: 2.980

2.  Fingertip Whole Blood as an Indicator of Omega-3 Long-Chain Polyunsaturated Fatty Acid Changes during Dose-Response Supplementation in Women: Comparison with Plasma and Erythrocyte Fatty Acids.

Authors:  Barbara J Meyer; Cassandra Sparkes; Andrew J Sinclair; Robert A Gibson; Paul L Else
Journal:  Nutrients       Date:  2021-04-23       Impact factor: 5.717

3.  Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial.

Authors:  Christine Dawczynski; Ursula Hackermeier; Martin Viehweger; Rainer Stange; Monika Springer; Gerhard Jahreis
Journal:  Lipids Health Dis       Date:  2011-08-04       Impact factor: 3.876

4.  Clinical Benefits of n-3 PUFA and ɤ-Linolenic Acid in Patients with Rheumatoid Arthritis.

Authors:  Mirjana Veselinovic; Dragan Vasiljevic; Vesna Vucic; Aleksandra Arsic; Snjezana Petrovic; Aleksandra Tomic-Lucic; Maja Savic; Sandra Zivanovic; Vladislava Stojic; Vladimir Jakovljevic
Journal:  Nutrients       Date:  2017-03-25       Impact factor: 5.717

5.  Secondary prevention of heart disease--knowledge among cardiologists and omega-3 (omega-3) fatty acid prescribing behaviors in Karachi, Pakistan.

Authors:  Saqib A Gowani; Sana Shoukat; Ather M Taqui; Hashim M Hanif; Wasiq F Rawasia; Zeeshan Qadri; Sajid H Dhakam
Journal:  BMC Cardiovasc Disord       Date:  2009-01-27       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.